BGI Genomics Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 1,563.364 million compared to CNY 791.193 million a year ago. Operating income was CNY 620.840 million compared to CNY 166.925 million a year ago. Net income was CNY 524.980 million compared to CNY 140.018 million a year ago. Basic earnings per share from continuing operations was CNY 1.2909 compared to CNY 0.35 a year ago. Diluted earnings per share from continuing operations was CNY 1.2841 compared to CNY 0.35 a year ago.